Gryphon Financial Partners LLC Ab Cellera Biologics Inc. Transaction History

Gryphon Financial Partners LLC

  • $736 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$9.2 - $13.68 $17,020 - $25,308
-1,850 Reduced 14.99%
10,490 $104,000
Q2 2022

Jul 28, 2022
BUY
$5.72 - $10.65 $10,582 - $19,702
1,850 Added 17.64%
12,340 $131,000
Q1 2022

May 05, 2022
BUY
$7.46 - $14.14 $78,255 - $148,328
10,490 New
10,490 $102,000

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email